🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

U.S. stocks fall ahead of earnings, eyes on Alcoa; Dow Jones down 0.45%

Published 07/09/2012, 09:52 AM
NDX
-
UK100
-
FCHI
-
DJI
-
DE40
-
STOXX50
-
JP225
-
HK50
-
CVX
-
AA
-
HGSI
-
GSK
-
XOM
-
CPB
-
PEP
-
IXIC
-
Investing.com - U.S. stocks opened lower on Monday, weighed by Friday’s weak employment data and as investors remained cautious ahead of a meeting of euro zone finance ministers later in the day, while second quarter earnings season was about to begin.

During early U.S. trade, the Dow Jones Industrial Average dropped 0.45%, the S&P 500 index declined 0.36% while the Nasdaq Composite index fell 0.23%.

Sentiment remained fragile after official data on Friday showed that the U.S. economy added just 80,000 jobs in June, below market expectations for a gain of around 90,000. It was the third consecutive month where hiring failed to top the 100,000-level.

Meanwhile, European Central Bank President Mario Draghi reiterated on Monday comments made at a press conference last week, saying that economic indicators for the second quarter point to weakening growth in the euro zone.

The comments came as the yield on Spain’s 10-year government bonds climbed to 7.11% earlier, above the 6% threshold, widely seen as unsustainable, ahead of a meeting of euro zone finance ministers later Monday to discuss plans to help the region’s struggling banking system.

Energy stocks were broadly lower as shares in oil and gas major Chevron fell 0.67% and Exxon Mobil dropped 0.71%, while Chesapeake Energy saw shares decline 0.45%.

U.S. aluminum producer Alcoa also tumbled 1.20%, as the company was preparing to kick off the earnings season, by publishing second quarter results after the closing bell.

On the upside, aircraft company Boeing jumped 1.52%, at the open of Europe's Farnborough air show, in the U.K., with orders from at least two leasing companies. The deals were believed to help the U.S. plane maker consolidate its lead in orders over Airbus this year.

Elsewhere, Apple shares advanced 0.72%, although Samsung Electronics won an intellectual property ruling against Apple, as a U.K. judge declared earlier that the Galaxy tablet isn’t “cool” enough to be confused with the design for the iPad.

In corporate news, Celgene added 0.29% amid reports it was one of two companies discussing whether to bid for Human Genome Sciences, which is seeking an alternative to a hostile offer by British drug maker GlaxoSmithKline.

WellPoint also gained 4.17% after announcing plans to buy rival Amerigroup for about USD4.46 billion.

Meanwhile, Campbell Soup saw shares rise 0.21% after saying it will acquire Bolthouse Farms for USD1.55 billion in cash, in an attempt for the packaged food and beverage giant to make their products healthier.

Other stocks in focus included PepsiCo, down 0.21%, as it was expected to start selling yogurt this month, in the Northeast and mid-Atlantic states, in a bid to curb its reliance on soda sales.

Across the Atlantic, European stock markets were lower. The EURO STOXX 50 eased 0.08%, France’s CAC 40 fell 0.13%, Germany's DAX declined 0.18%, while Britain's FTSE 100 retreated 0.47%.

During the Asian trading session, Hong Kong's Hang Seng Index plunged 1.7%, while Japan’s Nikkei 225 Index tumbled 1.4%.

Also Monday, government data showed that consumer price inflation accelerated at the slowest rate since January 2010 in June, sparking fresh concerns over a deeper-than-expected slowdown in China.

Premier Wen Jiabao said over the weekend that China’s economy faces “relatively large” downward pressure in the near-term.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.